Targeted expression of MYCN causes neuroblastoma in transgenic mice.
about
NCYM, a Cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3β resulting in the stabilization of MYCN in human neuroblastomasSmall molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastomaTRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cellsDrugging MYCN through an allosteric transition in Aurora kinase ASIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stabilityNB4S, a member of the TBC1 domain family of genes, is truncated as a result of a constitutional t(1;10)(p22;q21) chromosome translocation in a patient with stage 4S neuroblastomaIdentification of ALK as a major familial neuroblastoma predisposition geneThe Skin as an Early Expression of Malignancies in the Neonatal Age: A Review of the Literature and a Case SeriesTranslational development of difluoromethylornithine (DFMO) for the treatment of neuroblastomaNatural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approachesSmall-molecule inhibitors of the Myc oncoproteinInvolvement of midkine in neuroblastoma tumourigenesisTherapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma.The zebrafish as a model for studying neuroblastomaFocal DNA copy number changes in neuroblastoma target MYCN regulated genesDickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastomaExploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy CombinationMolecular pathogenesis of peripheral neuroblastic tumorsIn vivo elimination of acentric double minutes containing amplified MYCN from neuroblastoma tumor cells through the formation of micronucleiAltered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cellsSparstolonin B, a novel plant derived compound, arrests cell cycle and induces apoptosis in N-myc amplified and N-myc nonamplified neuroblastoma cellsTL-118 and gemcitabine drug combination display therapeutic efficacy in a MYCN amplified orthotopic neuroblastoma murine model--evaluation by MRIInhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumorsNeuroblastoma, a Paradigm for Big Data Science in Pediatric Oncology.Th-MYCN mice with caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis.N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis.N-MYC regulates focal adhesion kinase expression in human neuroblastoma.Galanin and galanin receptor expression in neuroblastic tumours: correlation with their differentiation status.Mutations in PIK3CA are infrequent in neuroblastoma.Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genesBCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRARalpha) to block neutrophil differentiation and initiate acute leukemia.Lack of correlation between MYCN expression and the Warburg effect in neuroblastoma cell lines.Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma.A simple PCR method for rapid genotype analysis of the TH-MYCN transgenic mouse.Enteric neural crest differentiation in ganglioneuromas implicates Hedgehog signaling in peripheral neuroblastic tumor pathogenesis.Upstream ORF affects MYCN translation depending on exon 1b alternative splicingInactivation of SMC2 shows a synergistic lethal response in MYCN-amplified neuroblastoma cells.The "neuro" of neuroblastoma: Neuroblastoma as a neurodevelopmental disorder.MYC oncogenes and human neoplastic disease.MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma
P2860
Q21092404-A714D594-E558-42BE-87E2-42E000351CA4Q24296639-7DE43D55-E22B-498D-83F1-0771877BFA85Q24297046-0458C4B3-3687-4200-BACD-F7FEEFE55C89Q24303381-EA2122B1-2E87-4DB1-A631-D82F33ED9CF3Q24307488-B303A39F-EEF5-4AEC-98F3-2E37DBA49EEFQ24322761-EC3DCF2A-60E0-4420-8E00-E56C82E5471AQ24655923-5A527F07-A683-4901-ABA1-78DECF44DF1DQ26769681-AEE73D6C-691A-470B-9D9A-F877D23FDF98Q26770306-2520A6D5-7E5D-4CDA-BDC0-C57620637262Q26825652-6919119B-B6E1-498D-8F5F-D308A2F56E3FQ27025648-0E98AE86-BA1D-44EA-A9FB-D95132D9CB22Q27026748-FA9F3A0C-3D36-49CB-8055-8537F236F3E0Q27853237-6C070287-4E2A-49E8-A92E-47394C48CFDDQ28070309-031AE5C4-E9E4-47E2-9220-641C860C4EFFQ28115604-3E4B197B-55F1-4F31-B522-7A419A316F9FQ28117269-8561479F-418A-4449-BE93-58B2D439F603Q28118450-F4DB4724-53B4-435F-AE55-C5D1232ED6BCQ28271405-ED1FE2BB-AD2F-4C28-88FF-485EA19DD7A8Q28364316-01A8B844-CFBE-4964-82BE-86A8F9DC10B5Q28377114-F19E9203-C24A-47BB-A053-B40C34114EF7Q28538332-9AEFAEA7-5185-446D-A278-AB18F1D1D6C7Q28540575-AB913E95-8138-4FF0-B910-5BE60F7F1BAFQ28817295-3D2C7B09-AD67-4B8C-B1C3-5159DEF89907Q30239861-C94E6809-23FB-4BB2-ACB9-80FB81DD6AEAQ30541198-91931BA5-7FB4-48D9-913F-C3675ACB8260Q30983520-34E12A6B-A4B2-43C6-8EB8-242EC20833D9Q31814799-F4BC42B0-91C2-41B7-A1E5-16FCA4778591Q33183408-A9C1AEED-78DF-4546-B981-17A081E5B90AQ33248957-C8CA9209-ABFC-49FA-ABF6-7BCF2ED000A9Q33258311-6F2C4382-F5D0-4688-BE4B-425B5674FCDFQ33335885-28519B27-FB88-4E55-94A0-A86A3046CBABQ33369231-9101C8A8-B3E3-49C9-9A9C-0294085672D6Q33490314-400171D0-246E-433A-8287-FFC3244EED41Q33500160-65C77087-37D0-4CE0-B523-6BD9D8C474D7Q33510925-4247BECE-9A3A-48C2-AF51-3F5B1B9D8D0FQ33519157-29BAEF23-C392-432E-866F-88E944F0204CQ33578581-F200C0F4-A916-4571-B494-2628B8DA3B83Q33643120-A93D89F3-C6BB-4B20-9066-B2E3CDE6BB49Q33667340-E2E73F40-30E3-4BAC-A5DD-6CB78D3CF564Q33667823-827005ED-081B-45DF-82D9-F14A31D0AB70
P2860
Targeted expression of MYCN causes neuroblastoma in transgenic mice.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
name
Targeted expression of MYCN causes neuroblastoma in transgenic mice.
@ast
Targeted expression of MYCN causes neuroblastoma in transgenic mice.
@en
type
label
Targeted expression of MYCN causes neuroblastoma in transgenic mice.
@ast
Targeted expression of MYCN causes neuroblastoma in transgenic mice.
@en
prefLabel
Targeted expression of MYCN causes neuroblastoma in transgenic mice.
@ast
Targeted expression of MYCN causes neuroblastoma in transgenic mice.
@en
P2093
P2860
P356
P1433
P1476
Targeted expression of MYCN causes neuroblastoma in transgenic mice.
@en
P2093
B G Feuerstein
G Mohapatra
J M Bishop
P2860
P304
P356
10.1093/EMBOJ/16.11.2985
P407
P577
1997-06-01T00:00:00Z